Mustang Bio MBIO

$ 0.25 -6.33%

Quarterly report 2024-Q2
added 08-13-2024

Mustang Bio Financial Statements 2011-2024 | MBIO

Annual Financial Statements Mustang Bio

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	9.98 M	8.91 M	87.9 M	239 M	136 M	91.9 M	307 M	-	-	-	-	-	-
Shares	8.6 M	7.68 M	87.9 M	57.3 M	36.1 M	26.9 M	25.3 M	-	-	-	-	-	-
Historical Prices	1.16	1.16	1.18	4.17	3.67	3.72	11.9	-	-	-	-	-	-
Net Income	-51.6 M	-77.5 M	-66.4 M	-60 M	-46.4 M	-30.7 M	-31.3 M	-12.7 M	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-49.3 M	-76.2 M	-66.7 M	-56.8 M	-45.9 M	-31.2 M	-31.8 M	-11.4 M	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-47.4 M	-73.4 M	-64.6 M	-54.3 M	-44.5 M	-30.6 M	-31.8 M	-11.3 M	-	-	-	-	-
Operating Expenses	49.3 M	76.2 M	66.7 M	56.8 M	45.9 M	31.2 M	31.8 M	11.4 M	-	-	-	-	-
General and Administrative Expenses	9.69 M	12.2 M	11 M	9.5 M	9.57 M	6.76 M	11.4 M	2.82 M	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Mustang Bio

	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	23.1 M	11.3 M	8.17 M	8.13 M	8.09 M	-	7.85 M	7.65 M	7.32 M	93.6 M	91.1 M	87.6 M	80.5 M	70.9 M	57.3 M	45 M	42 M	39.4 M	39.9 M	36.3 M	27.9 M	26.6 M	27.1 M	27.1 M	26.4 M	25.2 M	26.2 M	26.2 M	22.4 M	15.2 M	10.1 M	10.2 M	10.1 M	2 M	10 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-8.2 M	-5.19 M	-10.1 M	-16.2 M	-16.7 M	-	-19 M	-19.1 M	-19.8 M	-	-17 M	-14.4 M	-15 M	-	-13 M	-14.6 M	-11.9 M	-16.2 M	-10.2 M	-10.4 M	-9.61 M	-11.8 M	-7.52 M	-5.09 M	-6.28 M	-15.6 M	-6.94 M	-5.53 M	-3.22 M	-8.75 M	-1.87 M	-1.13 M	-903 K	-911 K	-716 K	-579 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-50 K	-	-	50 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-8.54 M	-5.23 M	-10.3 M	-13.9 M	-16.3 M	-	-18.8 M	-18.2 M	-19.6 M	-	-17.1 M	-14.4 M	-15.1 M	-	-10.4 M	-14.1 M	-11.5 M	-15.9 M	-10 M	-10.2 M	-9.75 M	-11.8 M	-7.66 M	-5.24 M	-6.48 M	-15.7 M	-7.08 M	-5.66 M	-3.31 M	-7.83 M	-1.67 M	-1.04 M	-822 K	-843 K	-658 K	-537 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-8.24 M	-4.95 M	-10 M	-13.3 M	-15.6 M	-	-18.1 M	-17.5 M	-19 M	-	-16.5 M	-13.9 M	-14.6 M	-	-10 M	-13.7 M	-11.1 M	-15.9 M	-9.7 M	-9.91 M	-9.47 M	-11.8 M	-7.46 M	-5.14 M	-6.47 M	-15.7 M	-7.08 M	-5.66 M	-3.31 M	-7.83 M	-1.67 M	-1.04 M	-822 K	-843 K	-658 K	-537 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	8.54 M	5.23 M	10.3 M	13.9 M	16.3 M	-	18.8 M	18.2 M	19.6 M	-	17.1 M	14.4 M	15.1 M	-	10.4 M	14.1 M	11.5 M	-	10 M	10.2 M	9.75 M	-	7.66 M	5.24 M	6.43 M	-	7.08 M	5.66 M	3.31 M	-	1.67 M	1.04 M	-	-	658 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	1.53 M	1.43 M	2.13 M	3.06 M	2.32 M	-	3.39 M	3.08 M	3.35 M	-	2.36 M	2.54 M	3.47 M	-	2.15 M	2.99 M	1.96 M	-	1.99 M	3.19 M	2.34 M	-	1.34 M	1.68 M	2.06 M	-	4.6 M	1.67 M	2.02 M	-	1.1 M	458 K	255 K	-	88 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency